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The inflammation produced by exposure to ultraviolet (UV) light has been well documented clinically and
histologically. However, the mechanisms by which mediators induce this clinical response remain poorly defined. It is
clear that photochemistry occurring after UV absorption must be responsible for initiating these events. Some of
these underlying mechanisms have been defined. After exposure to UV light, the formation of prostaglandins and the
release of histamine are increased. In addition to an increase in the quantity of these mediators, an increase in
sensitivity of irradiated tissue to agonist stimulation also occurs. This increased sensitivity may cause tissue to respond
to agonist levels previously present. Phospholipase activity also increases, making more substrate available for
prostaglandin formation. Oxygen radical – induced peroxidation of membrane lipids caused by irradiation may
contribute to increased phospholipase activity. Oxygen-free radicals also participate in sunburn cell formation and in
UV-induced decreases in Langerhans cell numbers. Several enzymatic and non-enzymatic mechanisms are present in
skin for reducing these highly reactive oxygen species. J Invest Dermatol 100.35S-41S, 1993
Exposure of the skin to an adequate dose of 200–400nm wavelength light
produces inflammation. Because ultraviolet light – induced injury can be
easily reproduced and quantified, it has often been studied as a model of
inflammation [1–3]. Distinct patterns of inflammation are produced by
exposure to specific wavelengths of light, probably due to different injury
mechanisms. Based on these differences in the pattern of erythema,
investigators generally divide the ultraviolet wavelengths into three main
groups for purposes of study. The shorter wavelengths (200 to 290 nm)
are called UVC or ‘‘germicidal radiation,’’ wavelengths between 290 and
320nm are termed mid-UV or UVB radiation, and those between 320
and 400nm are designated UVA or long-wave UV [4].
CLINICAL AND HISTOLOGIC ALTERATIONS
INDUCED BY UV EXPOSURE
The physiologic response to UV light exposure has been carefully
documented. Acute exposure results in erythema, heat, edema, pain, and
pruritus, followed by tanning and epidermal thickening. Chronic
exposure can induce skin aging and carcinogenesis [5,6]. When
erythema is environmentally induced (primarily by UVB wavelengths),
this reaction to light is termed sunburn.
The dose of light needed to produce erythema, and the time course of
its development and color, are dependent on the wavelength of light
responsible for erythema production [1,7,8]. For example, the intensity of
UVC-induced erythema increases very gradually in response to increas-
ing doses of light, producing a flat dose-response curve. Both UVB and
UVA produce erythema at lower exposure doses, and erythema intensity
increases sharply as a function of the exposure dose [9]. Thus, the dose-
response curve for erythema production is a function of wavelength.
The wavelength of incident light also influences erythema duration.
Shorter wavelengths of light produce erythema of shorter duration; UVC
erythema fades within 3 h of exposure but UVA or UVB erythema may
persist for days. This difference in the intensity of the inflammatory
response to various wavelengths of light may be due in part to differences
in their penetration of the skin. UVC wavelengths are absorbed
completely by the epidermis, UVB wavelengths penetrate the epidermis
and are nearly fully absorbed in the upper dermis, and UVA penetrates to
the deep dermis [10].
The clinical pattern of erythema produced after UVB exposure may
be biphasic (particularly in the guinea pig and the rat) with a transient
immediate phase beginning in seconds and lasting only a few minutes. A
prolonged delayed phase begins subsequently, which generally has its
onset in 3 to 5 h, is maximal between 12 to 24h, and fades over 72 h
[11]. This time course may be manipulated by the exposure dose; small
doses produce short-lived erythema, whereas larger doses produce
erythema that is faster in onset, more intense, and persistent [6].
These changes differ somewhat from those observed after UVA
irradiation. Erythema induced by UVA without psoralen photosensitiza-
tion may produce a biphasic response depending on the dose of light
administered. After exposure to 2.5 times the minimal erythema dose,
erythema begins immediately, and peaks at 8 h. Erythema persists 24 to
48h [3,12], depending on the dose of UVA. UVA radiation doses
required to produce inflammation are about 1000 times greater than for
UVB doses.
The histology of immediate erythema due to UVB exposure has been
characterized in the guinea pig and rat [1,2] because its existence in
humans is usually not clinically apparent [8]. In immediate erythema, the
histologic changes are localized to the dermal vasculature; vasodilation
is present in arterioles, capillaries, and venules [13]. Similar histologic
changes are evident early in UVA-induced inflammation. The underlying
mechanism is unknown, but may be due in part to the effects of
vasoactive mediators [14].
The histology of changes occurring during the delayed phase of UV-
induced erythema has been well documented. The shorter wavelengths
(200 to 320nm) result in both epidermal and dermal changes whereas more
pronounced dermal injury results primarily from longer wavelengths. This
pattern of inflammation correlates with the difference in the capacity of
these wavelengths to penetrate the skin [10]. After exposure to three times
the minimal erythema dose of UVB, some sunburn cells appear in the skin
as early as 30min. These cells are dyskeratotic keratinocytes with dark
vacuolated cytoplasm and enlarged nuclei. They appear first in the lower
half of the epidermis, and by 24h after exposure are present in the upper
layers of the epidermis [11]. It is hypothesized that these cells are produced
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due to an inability to repair DNA damage adequately or as a result
of lysosomal breakdown [15,16]. Actively cycling cells rather than
differentiated cells are more likely to form sunburn cells after exposure to
UVB [17].
After UVB exposure, the number of resident Langerhans cells seen on
histologic examination of skin specimens stained by hematoxylin and
eosin decreases by 25% within 1 h. By 24 to 72h, only 10% of the
Langerhans cell population remains [11]. Others have confirmed
UVB-induced decreases in Langerhans cells in murine epidermis exposed
to low-dose (0.5 MED) UVB daily for 4 d. Adenosine triphosphatase
(ATPase)-positive Langerhans cells numbers decreased to 5% of control
values, a decrease that did not return to normal for 8 d [18]. Increased
vacuolization in melanocytes occurs by 1h after UVB exposure and
returns to baseline by 4 to 24h. In the dermis, endothelial cell swelling is
noted as early as 30min after exposure. Swelling increases over the
next 24 h, persisting for as long as 72 h after UVB. In addition, a slight
perivascular lymphocytic infiltrate is evident 24 to 72 h after UVB
exposure [11]. Mast cell number and granularity in papillary and reticular
dermis are decreased at 1 h and appear to return to normal at 24 to 72h
post–UVB irradiation. Later, by 24 to 48h, melanin synthesis, epidermal
proliferation, and thickening of the stratum corneum occur [6].
The histologic changes associated with UVA erythema differ from
UVB-induced tissue damage with respect to the greater dermal changes
produced by the longer wavelengths [19]. Epidermal injury resulting from
long-wave UV is characterized by spongiosis with a conspicuous
absence of sunburn cells [5]. There is a dense mononuclear cell infiltrate
with a few neutrophils that may extend into deep dermis. Vascular
damage may be severe with endothelial swelling, extravasation of red
blood cells and extravascular fibrin deposition [20]. The range of effects
varies with the intensity of UV light administered; high-dose UVA
irradiation results in marked dermal damage [8]. It has been suggested
that UVA-induced erythema may be related to keratinocyte cytotoxicity.
This hypothesis is based on a comparison of action-spectra data for
erythema and cytotoxicity that is essentially superimposable [21].
LIGHT ABSORPTION BY SKIN CHROMOPHORES
RESULTS IN PHOTOCHEMISTRY
UV-induced inflammation is the result of chemical reactions occurring in
the skin initiated by incident light. When light falls upon the skin it may
be scattered, reflected, or absorbed. Only absorbed light can produce
chemical changes in light-absorbing molecules, a process termed
photochemistry. When light is absorbed, the absorbing molecule is
called a chromophore. The range of wavelengths of light with sufficient
energy to cause a chemical change in the chromophore is termed the
absorption spectrum of that chromophore, and is specific for each
substance. The sum of the photochemical reactions occurring when light
interacts with chromophores present in skin initiates UVR injury, which
in turn results in the biochemical and immunologic perturbations that
cause inflammation [6]. Because different wavelengths of light may be
absorbed by different chromophores, the pattern of inflammation
occurring after exposure to radiation of differing wavelengths is altered
(Fig 1). The shorter wavelengths (less than 300nm) act on nucleic acids,
amino acids, urocanic acid, and melanin as the major chromo-
phores whereas melanin is the chromophore at longer wavelengths
(350–1200nm) [22]. In addition, the amount and location of chromo-
phores in the skin, as well as variations in epidermal thickness, determine
the degree to which UVR is absorbed [6].
Details of the linkage between photochemical reactions and the
biochemistry that produces a given clinical response are not defined in
most cases. However, UV radiation – induced changes have been
documented in a number of cellular biochemical pathways. UV
absorption by nucleic acids leads to pyrimidine dimer formation [23].
UVB and UVC are effective inducers and promoters of skin cancer in
mice [24], although the carcinogenic potential of UVA is not well
established. In general, UV radiation enhances the production of
metabolites of arachidonic acid [11,25,26], inflammatory cytokines
[27], adhesion molecules [28], and mast cell-derived mediators [29].
Reactive oxygen species are also generated by UVR exposure, which can
result in membrane lipid peroxidation and destruction. Although the
exact photochemistry is not well understood, lipid mediators, reactive
oxygen radicals, effects on DNA, and immune mechanisms undoubtedly
interact to produce UV-induced inflammation. This review focuses on
lipid mediator generation and the mechanisms that have evolved to
combat membrane oxidative damage induced by ultraviolet radiation in
the skin.
PROSTAGLANDINS AS MEDIATORS OF UV INJURY
Eicosanoids, 20-carbon fatty-acid mediators synthesized from arachido-
nic acid present in membrane phospholipids, play a prominent role as
soluble mediators of the delayed erythema response. As evidence for this,
the production of tissue eicosanoids parallels the onset of erythema, and
eicosanoid inhibitors decrease UVB erythema. The pattern of eicosanoid
synthesis initiated by ultraviolet light depends on the wavelength and
probably represents a mixture of the eicosanoid synthetic profile of the
cell types present in skin [25,30]. Studies of the effects of UVB on
cutaneous eicosanoid synthesis have been done on suction blister fluid
exudates and on cells in culture. In both settings, eicosanoid metabolism
is enhanced (Table I). Metabolites of arachidonic acid (AA) prostaglandin
E2 (PGE2), PGD2, PGF2a, and 12-HETE are increased in suction blister
aspirates immediately following exposure to UVB (before onset of
noticeable erythema) and persist for 48 h, with peak concentrations
present at 18 to 24h [11,30–32]. The quantity of PGD2, a mast cell-
derived prostaglandin, rises in a pattern similar to that of keratinocyte-
derived PGE2 and PGF2a, implying a contribution of the mast cell to
UVB-induced inflammation. Prostacyclin (as measured by its metabolite
6-keto-PGFla), which is likely to be derived from vascular endothelium,
increases within 5 to 9 h post-irradiation and returns to baseline levels by
24 to 48h [2,6,29]. The increase in prostaglandin and HETE formation
after UVB irradiation may simply be due to increases in the release
of membrane arachidonic acid, as the release of free arachidonic
acid from membrane phospholipids is rate limiting in the synthesis
of these compounds [33]. Studies of cultured cells support the
contribution of enhanced phospholipase activity [34–36]. In human
epidermal cultures, release of AA occurs in a dose-dependent fashion
after UVB irradiation [35], a change that is confirmed by associated
increases in glycerophosphorylcholine release derived from membrane
phos-phatidycholine [25].
Figure 1. UV absorption spectra of major epidermal chromophores. DOPA-
melanin, 1.5mg% in H2O; urocanic acid, 10
4M in H2O; calf thymus DNA,
10mg% in H2O (pH 4.5); tryptophane, 2 104M (pH 7); tyrosine,
2 104M (pH 7). Reproduced by permission, Dr. R. Anderson [22].
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Evidence for a role for arachidonic acid cyclooxygenase products in
UV induced erythema is supported by the reduction of erythema by
selective inhibitors [37]. UVB erythema is suppressed by the cycloox-
ygenase inhibitors aspirin and indomethacin up to 50% during the first
24 h after injury [31,38–40]. However, erythema persisting after 24 h is
not suppressible by indomethacin, and may therefore be due to other
mediators. Unfortunately, interpretation of inhibitor studies to document
the mechanism of UV injury is limited by difficulty validating drug
efficacy in all responding cell types.
Examination of eicosanoid metabolism after UVA exposure reveals
some similarities with the effects of UVB exposure. UVA, like UVB,
increases the concentrations of AA, PGD2, PGE2, and the prostacyclin
metabolic product 6-keto-PGF1a in suction blister aspirates (Table I). The
time course of mediator synthesis reaches a maximum concentration at
5 to 9 h, declines by 15h, and returns to control levels by 24h [29]. The
increase in mediator formation observed is linearly dependent on the
UVA dose. The rise of eicosanoids corresponds to the time course of
observed erythema, suggesting a role for these substances in the complex
inflammatory response [29]. Similar studies in vitro using fibroblasts
corroborate an increased release of eicosanoids following UVA irradia-
tion [41]. However, topical or intradermal indomethacin in the
concentrations tested had no effect on UVA-induced erythema [42].
Inhibitor studies are inherently problematic because of the inability to
demonstrate adequate drug delivery to the epidermis.
In addition to their likely role in mediating UV erythema, eicosanoids
may be mediators of some of the other changes occurring in UV-
irradiated tissue. PGE2 has been shown in vivo to mediate the
suppression of contact sensitization that occurs in irradiated skin [43].
It can also increase plasma exudation, as can LTC4 [44]. Leuko-triene B4
is one of the most potent chemotactic substances known, and may
therefore play a role in the inflammatory cell influx that occurs [33,45].
Keratinocytes can also synthesize 12-R-HETE, a compound that could
influence cellular water balance by inhibition of Naþ -Kþ ATPase in
irradiated cells [46–49]. Epidermal keratino-cyte proliferation in culture is
regulated by PGE2, and may have this same effect in vivo [34,50]. In
addition, PGE2 released from irradiated cultures parallels their release of
the epidermal cytokine IL-1 following UVB irradiation, suggesting a
relationship between the synthesis of these two compounds [51].
Although progress has been made in elucidating the contribution of
eicosanoids to UV-induced inflammation in vitro, further work is
necessary to better define these processes in vivo.
UV IRRADIATION ENHANCES HISTAMINE-
STIMULATED PROSTAGLANDIN SYNTHESIS
Data that suggest that histamine must play a role in the erythema
response have been obtained by many investigators [2,11,52,53].
Inhibitor studies have established the relationship between histamine
and the erythema response in several animal models. In guinea pigs,
erythema occurring up to 120min post-irradiation is suppressible with
antihistamines [2,54]. In rats, an antihistamine-suppressible component
occurs during the delayed erythema phase [2]. In humans, mast cells
have been shown to degranulate and release histamine 4 h after exposure
to UV light [11,53]. At the same time, aspirates from suction blisters
overlying irradiated skin contain elevated levels of histamine [11]. Others
have documented elevations of histamine peaking 9 to 15h after
irradiation and returning to baseline by 24h [29].
Studies using skin explants irradiated in vitro suggest that histamine-
stimulated prostaglandin synthesis is an underlying mechanism early in
the delayed phase of the human erythema response. UV-stimulated prost-
aglandin synthesis is inhibited by the presence of the HI antihistamines
brompheniramine or pyrilamine, but is not influenced by the H2
antagonist cimetidine (Fig 2) [55]. Further studies using cultured cells
reveal that increased prostaglandin synthesis is primarily due to an
increase in the sensitivity and maximal response of irradiated keratino-
cytes (Fig 3) and fibroblasts to agonist stimulation (Fig 4). The increased
response of irradiated cells to agonist stimulation is not restricted to
histamine, but is also observed with bradykinin, indicating that
irradiation increases sensitivity to multiple agonists. This increased
sensitivity to stimulation imparted by irradiation implies that mediators
may contribute to UV-induced inflammation even when the injury
does not increase the quantity of the mediator in tissue [56]. Clearly,
the inflammatory potential of a mediator must be assessed both by
changes in its concentration as well as the capacity of the stimulated
tissue to respond.
OXYGEN RADICALS CONTRIBUTE TO
UV-INDUCED INFLAMMATION
One underlying mechanism for the initiation of UV-induced erythema
may be the photochemical production of activated oxygen species
[57–59]. Oxygen radicals are known to cause a number of disruptive
cellular processes, including lipid peroxidation, cleavage of DNA,
altered enzyme activity, polymerization of polysaccharides, and cell
death. These products are also produced physiologically in numerous
ways, including the microbicidal action of phagocytic neutrophils and
autoxidation of metabolites such as hydroquinones, catecholamines, and
thiols [60]. Because radical production occurs physiologically, the cell
has several mechanisms for their removal. The oxygen radicals are
reduced in biologic systems by electron transfer to produce water. This
reduction process results in the formation of reactive intermediates
including superoxide anion (O2
, hydrogen peroxide (H2O2), and the
hydroxyl radical (OH) [59]. UVB-induced oxygen radicals are produced
from photolysis of water, cysteine-containing epidermal proteins, and in
the course of enzyme/substrate reactions [61,62]. It is likely that UV
irradiation produces inflammation when the cellular capacity to reduce
oxygen radicals is exceeded.
LIPID PEROXIDATION MAY BE AN INITIAL EVENT
FOR LIPID MEDIATOR RELEASE
Lipid peroxidation induced by oxygen radicals has been linked
circumstantially to increased formation of lipid mediators such as
prostaglandins. Lipid peroxidation is a free-radical – induced chain
reaction that occurs when superoxide anion and hydrogen peroxide form
hydroxyl radicals in the presence of redox active metals such as iron
[63–65]. These hydroxyl radicals then react with nearby polyunsaturated
fatty acids to abstract hydrogen. Subsequent to this initiation reaction, a
propagation phase occurs in which a peroxidative chain reaction spreads
through the membrane, generating new radical species as the reaction
Table I. Pattern of Metabolite Formation After UV
Exposurea
Metabolite (ng/ml) Control 5–9 h 25h 48 h
UVA
AA 2122±342 3561±1041 2389±439 1917±547
PGD2 46±10 161±42 56±10 31±15
PGE2 36.9±12 102.3±32.3 61.8±16.4 24.5±10.4
UVB
AA 276.3±19.5 360.2±69.3 785±56.8 232.9±24.4
PGD2 21.8±1.3 35±47 34.9±6.7 34.3±4.8
PGE2 17.06±0.7 28.2±3.3 49.4±5.2 19.2±0.8
PGF2a 18.2±1.1 ND 32.4±2.9 ND
aRecoverable levels (mean±SEM) of AA, PGD2, PGE2, and PGF2a
measured by gas chromatography–mass spectroscopy in suction blister
exudates raised over irradiated human skin. UVA data obtained after
exposure to 2.5 MED (by permission from Hawk [29]). UVB data obtained
after exposure to three MED (by permission from Black [30]). ND, not
done.
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proceeds. This oxygen-dependent process is enhanced by NADPH and
Feþþþ -ADP [66]. The importance of lipid peroxidation in mediating
injury is well established in several trauma injury models [63,67–69].
Peroxidation has recently been demonstrated in irradiated epidermis,
together with evidence showing that the natural antioxidants ubiquinone
and vitamin E are depleted, suggesting it has a role in mediating UV
injury as well [70].
A possible mechanism by which lipid peroxidation may initiate
inflammatory events is via activation of phospholipases. Lipid peroxida-
tion has been shown to increase phospholipase A2 (PLA2) activity in rat
liver microsomes and to increase phospholipase C (PLC) activity in
cardiac sarcoplasmic reticulum, rat liver lysosomes, and brain [43,71].
Increased release of AA suggesting increased phospholipase activity, has
been documented after UV exposure [35,36,55] although it has not yet
been directly linked to peroxidation of membrane lipid occurring during
UV exposure. Increased activity of PLA2 results in increased amounts of
free AA (the substrate for prostaglandin formation). The immediate
increase in pros-taglandin formation found after UV exposure [30]
supports the hypothesis that peroxidation-induced increases in phospho-
lipase activity act as an initiating mechanism. In addition, peroxidation-
induced increases in the activity of PLC would result in enhanced
diacylglycerol release (a co-factor for protein kinase C). Evidence to
support such a mechanism has recently been obtained in UVA injury,
where increased synthesis and activity of protein kinase C have been
documented in UVA irradiated fibroblasts [72]. This alteration may be
responsible for enhanced cellular proliferation, as well as promotion of
carcinogenesis, because protein kinase C has been reported to mediate
these effects in other systems [73].
Figure 2. Brompheniramine, but not cimetidine, suppresses irradiated
ex-plant prostaglandin synthesis. Control or irradiated explants were
incubated with 50mM brompheniramine ( ), 30 mM cimetidine ( ), or 1 mM
indo-methacin (’) or no addition (&). The average release of prostaglandin
was then determined 6h after irradiation. Quadruplicate determinations from
a representative experiment are shown. The experiment was repeated with
similar results (reproduced by permission from J Clin Invest 86:566–574,
1990) [55].
Figure 3. Irradiation increases the response of epidermal cultures to
bradykinin stimulation. Control (K) or irradiated (J) cultures were
incubated with 1 nM to 10 mM bradykinin for 15min, and the synthesis of
PGE2 and PFG2a/mg protein determined. The average values from three
experiments±the SEM are shown; pp0.1, Student paired t test (reproduced
by permission from Am J Physiol 261:R543–R547) [56].
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EPIDERMAL ANTIOXIDANTS OFFER PROTECTION
FROM UV INJURY
Due to its location adjacent to the oxygen-rich extracellular environment,
epidermis requires well-developed defenses against oxygen radical
damage. Enzymatic mechanisms that may repair oxidation injury
induced by UV include superoxide dismutase [59], catalase [74], and
thioredoxin reductase [58]. There are also high concentrations of
molecules, such as urocanic acid and melanin, that harmlessly absorb
and scatter incident UV radiation, thereby preventing oxygen radical
formation [6]. Natural antioxidants, including vitamins A, E, and C, as
well as reduced glutathione, also act to prevent oxygen radical damage
(Table II). Despite this, epidermis remains susceptible to damage by light-
induced oxidative damage if sufficient exposure occurs, as demonstrated
by the protection against photocarcinogenesis afforded by antioxidants in
the diet [75,76] and the attenuation of UV damage by antioxidants [77].
Glutathione, a cysteine-containing tripeptide, is distributed through-
out the cell and is an endogenous antioxidant [78]. Its many functions
include oxygen radical scavenging as well as being a co-factor for the
synthesis of AA metabolites such as leukotrienes and prostaglandins [79].
In tissues, glutathione is maintained in reduced form, where its reducing
potential helps maintain cellular function by the reduction of oxidized
tissue components such as lipid peroxides. Its reducing capacity is also
used in the regeneration of cellular antioxidants such as vitamin C to their
reduced state [74]. The role of glutathione in modulating UV injury has
been implicated in several studies. The protective effects of glutathione
have been shown in cultured human fibroblasts, and in hairless mice,
where its presence was found to decrease the cytotoxic effects of UVB
[80,81]. Its importance in protecting the skin from oxidant injury is also
supported by the observation that ultraviolet exposure depletes
glutathione [82,83].
The epidermal thioredoxin system [58] is an epidermal membrane-
associated free radical scavenging system that catalyzes the reduction of
oxygen radicals to peroxide ions that are then reduced to water. Although
it is widely distributed in a variety of organisms and tissues, the location
of the enzyme system at the outer membrane surface in human epidermis
suggests it may be a first line of defense against free radical production
induced by UV light [84]. One of its functions in epidermis is probably to
prevent membrane lipid peroxidation and inactivation of sulfur-contain-
ing amino-acid compounds. Interestingly, activity of thioredoxin
reductase is decreased 30% in vitiliginous skin, implicating free-radical
damage in the pathogenesis of this disease.
Catalase is a heme protein that catalyzes the dismutation reaction of
hydrogen peroxide to form water and oxygen [74]. It functions with
glutathione to remove hydrogen peroxide from the cell and decreases the
likelihood of the hydrogen peroxide combining with superoxide anion to
form the highly reactive hydroxyl radical (Haber-Weiss reaction).
Catalase is found in skin, liver, and blood cells where it is important in
protecting against oxygen toxicity, and is depleted by UV exposure [74].
Superoxide dismutases are a family of metalloproteins that catalyze
the removal of superoxide radicals (O2
) by combination with hydrogen
ions (Hþ ) to form H2O2 and O2. In human epidermis, the active site may
contain both copper and zinc (CuZn-SOD); others have manganese
(Mn-SOD) at their active site [85]. Superoxide dismutases are present in
both mitochondria (primarily Mn-SOD) and cytosol of epidermal cells
and function as an adaptive mechanism to protect the cells against the
damage of oxygen-free radicals.
The importance of antioxidant systems in the protection of skin from
UV injury has been studied by several investigators. Sunburn cells are a
marker for UVB-induced epidermal injury and have been the histologic
marker assessed in many of these studies [77]. Miyachi and colleagues
found a dose-dependent decrease in the number of sunburn cells in
mouse skin explants treated with antioxidants. Superoxide dismutase,
catalase, and xanthine, which quenches singlet oxygen and hydrogen
peroxide, all inhibit UV-induced sunburn cell formation [86]. The
protective effect of superoxide dismutase was also demonstrated in vivo
in mice by Danno and colleagues, who showed the antioxidant
prevented the formation of sunburn cells [87]. This protection occurred
whether the superoxide dismutase was given before or with 15min after
irradiation. However, UV-induced ear swelling (edema) was not affected
by these substances, suggesting a different mechanism is responsible for
this effect of UV injury.
Oxygen intermediates may also be partially responsible for
the decrease in the epidermal Langerhans cell population that occurs
after UV exposure [88]. In UVB-irradiated guinea pig skin, partial
protection of the Langerhans cell population is achieved by intra-dermal
injection of superoxide dismutase. However, erythema reduction by
Figure 4. Irradiated fibroblasts synthesize increased quantities of
prostaglandin when stimulated with bradykinin. Fibroblasts were exposed
to 0–30mJ/cm2 UV 6h prior to stimulation with 1mM bradykinin (BK).
Unstimulated (K), þ BK (J). This increase in synthesis is dependent on the
dose of light to which the cells have been exposed, pp0.01 by Jonckeere’s
distribution-free test for ordered alternatives. Each point represents the
mean±SEM for three experiments (reproduced by permission from Am J
Physiol 261:R543–R547) [56].








2O2 þ 2Hþ þ 2GSH!GSSGþ 2H2O2
2OH þ 2GSH!GSSGþ 2H2O
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aSOD=superoxide dismutase; O2
=superoxide anion; GSOX=cysteic acid;
H2O2=hydrogen peroxide; GHS=reduced glutathione; OH
=hydroxyl
radical; GSSG=oxidized glutathione; O2*=singlet oxygen.
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indomethacin has no effect on UV-induced reduction in Langerhans cell
numbers [89], indicating that discrete mechanisms for this damage exist
that do not involve prostaglandin production.
In summary, although the clinical and histologic effects of ultraviolet
light exposure on the skin have been documented in detail, much
remains to be discovered about the mechanisms by which light interacts
with skin chromophores to produce ultraviolet injury. A better under-
standing of these processes should improve phototherapy and the
treatment of sunburn. In addition, because it is likely that perturbations
of normal mechanisms result in photosensitive conditions such as
lupus, understanding the mechanisms underlying ultraviolet light injury
should be useful in the understanding and treatment of photosensitivity
disorders.
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